Early selection of a new UL97 mutant with a severe defect of ganciclovir phosphorylation after valaciclovir prophylaxis and short-term ganciclovir therapy in a renal transplant recipient

Antimicrob Agents Chemother. 2005 Apr;49(4):1580-3. doi: 10.1128/AAC.49.4.1580-1583.2005.

Abstract

We describe the emergence of a new ganciclovir resistance mutation in the UL97 gene of human cytomegalovirus, deletion of codon 601, after valaciclovir and short-term ganciclovir therapy following kidney transplantation. Its role in ganciclovir resistance was supported by decreased ganciclovir phosphorylation in a recombinant vaccinia virus system.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acyclovir / analogs & derivatives*
  • Acyclovir / therapeutic use
  • Adolescent
  • Antiviral Agents / pharmacology*
  • Antiviral Agents / therapeutic use
  • Chemoprevention
  • Codon
  • Cytomegalovirus / drug effects*
  • Cytomegalovirus / genetics
  • Cytomegalovirus Infections / drug therapy
  • Cytomegalovirus Infections / virology
  • Drug Resistance, Viral / genetics*
  • Ganciclovir / metabolism
  • Ganciclovir / pharmacology*
  • Ganciclovir / therapeutic use
  • Humans
  • Kidney Transplantation / adverse effects*
  • Molecular Sequence Data
  • Phosphorylation
  • Phosphotransferases (Alcohol Group Acceptor) / genetics*
  • Sequence Deletion*
  • Valacyclovir
  • Valine / analogs & derivatives*
  • Valine / therapeutic use

Substances

  • Antiviral Agents
  • Codon
  • Phosphotransferases (Alcohol Group Acceptor)
  • ganciclovir kinase
  • Valine
  • Valacyclovir
  • Ganciclovir
  • Acyclovir

Associated data

  • GENBANK/AY681345